Prostate Cancer
Reviews

Volume 7 Number 4
April 2019

Home > Disciplines > Publications > Prostate Cancer Reviews > Volume 7, Year 2019 > Number 4, April

CONTENTS

▼

DIAGNOSIS
ETIOLOGY, PATHOGENESIS, PATHOLOGY
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
TREATMENT

DIAGNOSIS

▲

.

Ahmadzadehfar H, Essler M.
Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning.
Eur Urol. 2019 Mar 2. pii: S0302-2838(19)30175-7. doi: 10.1016/j.eururo.2019.02.028. [Epub ahead of print]
Source . Similar articles
Referring to: Perera M et al., Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. Eur Urol. 2019 Feb 14. pii: S0302-2838(19)30095-8. doi: 10.1016/j.eururo.2019.01.049. [Epub ahead of print]. Source . Similar articles

.

Cimadamore A, Scarpelli M, Santoni M, Massari F, Tartari F, Cerqueti R, Lopez-Beltran A, Cheng L, Montironi R.
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy.
Curr Drug Metab. 2019 Feb 25. doi: 10.2174/1389200220666190225124352. [Epub ahead of print]
Source | Abstract | Similar articles

.

Diao W, Cai H, Chen L, Jin X, Liao X, Jia Z.
Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals.
Curr Top Med Chem. 2019 Jan 31. doi: 10.2174/1568026619666190201100739. [Epub ahead of print]
Source | Abstract | Similar articles

.

Egevad L, Delahunt B, Yaxley J, Samaratunga H.
Evolution, controversies and the future of prostate cancer grading.
Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29.
Source : Similar articles

.

Kdadra M, Höckner S, Leung H, Kremer W, Schiffer E.
Metabolomics Biomarkers of Prostate Cancer: A Systematic Review.
Diagnostics (Basel). 2019 Feb 19;9(1). pii: E21. doi: 10.3390/diagnostics9010021.
Source . Similar articles

.

Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, Christidis D, Bolton D, Hofman MS, Lawrentschuk N, Murphy DG.
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
Eur Urol. 2019 Feb 14. pii: S0302-2838(19)30095-8. doi: 10.1016/j.eururo.2019.01.049. [Epub ahead of print]
Source . Similar articles

.

Sun Y, Reynolds HM, Parameswaran B, Wraith D, Finnegan ME, Williams S, Haworth A.
Multiparametric MRI and radiomics in prostate cancer: a review.
Australas Phys Eng Sci Med. 2019 Feb 14. doi: 10.1007/s13246-019-00730-z. [Epub ahead of print]
Source . Similar articles

.

Tsuzuki T.
Editorial comment on Evolution, controversies and the future of prostate cancer grading.
Pathol Int. 2019 Feb;69(2):67. doi: 10.1111/pin.12773. Epub 2019 Feb 9.
Source . Similar articles
Referring to: Egevad L et al, Evolution, controversies and the future of prostate cancer grading. Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29. Source . Similar articles

.

Vapiwala N, Hofman MS, Murphy DG, Williams S, Sweeney C.
Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart.
J Clin Oncol. 2019 Feb 22:JCO1801927. doi: 10.1200/JCO.18.01927. [Epub ahead of print]
Source . Similar articles

ETIOLOGY, PATHOGENESIS, PATHOLOGY

▲

.

Robles LA, Dawe K, Martin RM, Higgins JPT, Lewis SJ.
Does testosterone mediate the relationship between vitamin D and prostate cancer? A systematic review and meta-analysis protocol.
Syst Rev. 2019 Feb 12;8(1):52. doi: 10.1186/s13643-018-0908-1.
Source . Similar articles

INTEGRATIVE MEDICINE

▲

.

Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N.
Obesity, Inflammation, and Prostate Cancer.
J Clin Med. 2019 Feb 6;8(2). pii: E201. doi: 10.3390/jcm8020201.
Source . Similar articles

.

Yedjou CG, Mbemi AT, Noubissi F, Tchounwou SS, Tsabang N, Payton M, Miele L, Tchounwou PB.
Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.
Nutrients. 2019 Feb 4;11(2). pii: E336. doi: 10.3390/nu11020336.
Source . Similar articles

OVERALL MANAGEMENT

▲

.

Esther J, Maughan BL, Anderson N, Agarwal N, Hahn AW.
Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.
Curr Treat Options Oncol. 2019 Feb 11;20(2):14. doi: 10.1007/s11864-019-0611-z.
Source . Similar articles

.

Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H.
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
J Urol. 2019 Mar 1;201(3):528-534. doi: 10.1097/JU.0000000000000071.
Source . Similar articles

.

Slaoui A, Albisinni S, Aoun F, Assenmacher G, Al Hajj Obeid W, Diamand R, Regragui S, Touzani A, Bakar A, Mesfioui A, Karmouni T, Ameur A, Elkhader K, Koutani A, Ibnattya A, Roumeguere T, Peltier A.
A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
World J Urol. 2019 Jan 31. doi: 10.1007/s00345-019-02652-7. [Epub ahead of print]
Source . Similar articles

TREATMENT

▲

.

Damodaran S, Lang JM, Jarrard DF.
Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches.
J Urol. 2019 Feb 7:101097JU0000000000000117. doi: 10.1097/JU.0000000000000117. [Epub ahead of print]
Source | Abstract | Similar articles

.

Faiena I, Kim IY, Jang TL.
Multimodal treatments for advanced prostate cancer.
Oncotarget. 2019 Jan 8;10(3):255-256. doi: 10.18632/oncotarget.26525. eCollection 2019 Jan 8.
Source . Similar articles

.

Fang D, Zhou L.
Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers.
Asia Pac J Clin Oncol. 2019 Feb 6. doi: 10.1111/ajco.13108. [Epub ahead of print]
Source . Similar articles

.

Farha NG, Kasi A.
Docetaxel.
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Feb 6.
Source . Similar articles

.

Gillian T et al, PDQ Adult Treatment Editorial Board.
Prostate Cancer Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Feb 5.
Source . Similar articles

.

James ND.
Oligometastatic Prostate Cancer Should Be Studied and Treated Differently to High-volume Disease. Con: The Underlying Biology is the Same, so They Should Not Be Treated Differently.
Eur Urol Focus. 2019 Feb 22. pii: S2405-4569(19)30021-5. doi: 10.1016/j.euf.2019.01.018. [Epub ahead of print]
Source . Similar articles

.

Kaiser A, Eley JG, Onyeuku NE, Rice SR, Wright CC, McGovern NE, Sank M, Zhu M, Vujaskovic Z, Simone CB 2nd, Hussain A.
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies.
J Vis Exp. 2019 Feb 6;(144). doi: 10.3791/58372.
Source . Similar articles

.

Pagliuca M, Buonerba C, Fizazi K, Di Lorenzo G.
The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer.
Drugs. 2019 Mar;79(4):381-400. doi: 10.1007/s40265-019-1060-5.
Source . Similar articles

.

Tucci M, Caffo O, Buttigliero C, Cavaliere C, D'aniello C, Di Maio M, Kinspergher S, Maines F, Rizzo M, Rossetti S, Veccia A, Scagliotti GV, Facchini G.
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.
Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.
Source . Similar articles

.

Witherspoon L, Breau RH, Lavallée LT.
Evidence-based approach to active surveillance of prostate cancer.
World J Urol. 2019 Feb 6. doi: 10.1007/s00345-019-02662-5. [Epub ahead of print]
Source . Similar articles

bottom

▲